We further compared the renal FGL2 gene expression in CKD patients and healthy controls, assessed the localization of FGL2 in kidney biopsies of CKD patients via immunohistochemistry and identified regulators of FGL2 gene expression in renal tissue using co-expression and upstream regulator analyses. This evidence concerns the gene FGL2 and chronic kidney disease.